Abstract
Myelopid and MP-1 myelopeptide increase the count of antibody-producing cells, reduced under the effect of injury and standard therapy, and do not modify the suppression of delayed hypersensitivity. Injections of myelopid and MP-3 together with standard drugs optimized the traumatic inflammation processes.
References
G. G. Avtandilov, Fundamentals of Quantitative Pathology [in Russian], Moscow (2002).
L. T. Arkhipova, Sympathetic Ophthalmia [in Russian], Moscow (2006).
V. P. Borovikov, Statistica. The Art of Computer Processing of Data: For Professionals [in Russian], St. Petersburg (2003).
T. V. Gavrilova and S. V. Gein, Immunomodulating Effects of Myelopeptides in Experimental Penetrating Wounds of the Eyes [in Russian], Ekaterinburg (2004).
R. V. Petrov, A. A. Mikhailova, and L. A. Fonina, Myelopeptides [in Russian], Moscow (2000).
M. V. Chereshneva, T. V. Gavrilova, Yu. I. Shilov, et al., Immunopatol., Allergol., Infektol., No. 2, 38–47 (2002).
M. V. Chereshneva, J. I. Shilov, V. A. Chereshnev, et al., Immunocorrection in Combined Therapy of Patients with Inflammatory Diseases of the Cornea and Vascular Membranes of the Eye [in Russian], Ekaterinburg (2004).
N. K. Jerne and A. A. Nordin, Science, 140, No. 3365, 405 (1963).
J. I. Shilov, S. V. Gein, and V. A. Chereshnev, Rus. J. Immunol., 6, No. 3, 301–308 (2001).
J. W. Streilein, Nature Rev. Immunol., 3, No. 11, 879–889 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 145, No. 3, pp. 313–315, March, 2008
Rights and permissions
About this article
Cite this article
Berkasova, N.L., Gavrilova, T.V., Shilov, J.I. et al. Effects of myelopeptides on immune response and morphometrical manifestations of inflammation in experimental penetrating wound of the eye. Bull Exp Biol Med 145, 341–343 (2008). https://doi.org/10.1007/s10517-008-0086-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-008-0086-6